Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder / Edna B. Foa en The Journal of Clinical Psychiatry, Año 2015 - Vol.76 - No.4 (Abril)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.4 (Abril) . - pp. 440-446 Título : Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder Tipo de documento: texto impreso Autores: Edna B. Foa, Autor ; Helen Blair Simpson, Autor ; David Rosenfield, Autor Fecha de publicación: 2020 Artículo en la página: pp. 440-446 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Terapia de modalidad combinada, Trastorno obsesivo-compulsivo, Risperidona, Inhibidores de la captación de serotonina. Resumen: To compare outcomes after 6-month maintenance treatment of adults diagnosed with obsessive-compulsive disorder (OCD) based on DSM-IV criteria who responded to acute treatment with serotonin reuptake inhibitors (SRIs) augmented by exposure and response prevention (EX/RP) or risperidone. Link: ./index.php?lvl=notice_display&id=21833 [artículo] Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder [texto impreso] / Edna B. Foa, Autor ; Helen Blair Simpson, Autor ; David Rosenfield, Autor . - 2020 . - pp. 440-446. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.4 (Abril) . - pp. 440-446 Palabras clave: Terapia de modalidad combinada, Trastorno obsesivo-compulsivo, Risperidona, Inhibidores de la captación de serotonina. Resumen: To compare outcomes after 6-month maintenance treatment of adults diagnosed with obsessive-compulsive disorder (OCD) based on DSM-IV criteria who responded to acute treatment with serotonin reuptake inhibitors (SRIs) augmented by exposure and response prevention (EX/RP) or risperidone. Link: ./index.php?lvl=notice_display&id=21833

---

1 (1 - 1 / 1)